Arizona MPJE (Pharmacy Jurisprudence) 2025 – 400 Free Practice Questions to Pass the Exam

Dronabinol, which is a synthetic form of THC (tetrahydrocannabinol), is classified under Schedule III of the Controlled Substances Act. This scheduling indicates that it has a potential for abuse but also has accepted medical uses, making it less restrictive than higher schedules. Schedule III drugs are available for prescription and can be considered for therapeutic use, particularly in treating conditions like nausea and vomiting associated with chemotherapy, as well as appetite stimulation in patients with AIDS.

In contrast, Schedule I substances are deemed to have no accepted medical use and have a high potential for abuse, which is not the case for Dronabinol. Schedule II includes drugs with a higher potential for abuse and greater restrictions, while Schedule IV and V represent substances with progressively lower potential for abuse. Understanding these classifications and the rationale behind them is essential for pharmacy practice and compliance with federal law.